Grand Challenges in Parkinson's Disease
The Role of Inflammation
September 18-19, 2013 Grand Rapids, Michigan
International Society of Nutrigenetics and Nutrigenomics 7th Annual Scientific Meeting (ISNN 2013)
October 5-8, 2013 Quebec City, Canada
Discover the latest findings on nutrigenetics and nutrigenomics as they relate to obesity, aging, cancer, diabetes and its cardiometabolic factors, inflammation and oxidative stress as well as translation into nutrition and personnalized medicine.
• Obesity, healthy body weight: implications for weight management
• Nutrigenetics of aging and cancer
• Inflammation and oxidative stress
• Type 2 diabetes and cardiometabolic risk factors
• Translation of “omics” into clinical practice
INAF – Université Laval
Pavillon des Services – Suite 1705
2440 Hochelaga Blvd.
Québec QC Canada G1V 0A6
Tel: 418-656-2131 x12564
3rd International Neural Regeneration Symposium
In conjunction with the 5th International Spinal Cord Injury Treatments and Trials Symposium
October 10th to 15th, 2013 Shenyang, Liaoning Province, China
INRS2013 is an international symposium organized by Chinese Rehabilitation Medical Association and Neural Regeneration Research (Press), aims to promote scientific exchange and collaboration for scientists and clinicians in neural regeneration research field internationally.
Following the tradition of previous meetings, INRS2013 will cover numerous aspects within the area of neural regeneration research, particularly those related to inflammation and neuroprotection, glial scar and neural regeneration, Neural repair and regeneration after spinal cord injury, stem cells and neural regeneration, translational medicine in neural regeneration, as well as alternative medicine and neural regeneration.
INRS 2013 Secretariat
Postal Address: P.O. Box 1234 Shenyang, China
Tel: +86 138 0499 8773; 187 0409 5273
8th Invest in ME International ME (ME/CFS) Conference 2013 Infection, Immunity and Myalgic Encephalomyelitis - Mainstreaming ME ResearchClinical and Research Updates
IIMEC8 - 31st May 2013 Westminster, London, United Kingdom
Research into Myalgic Encephalomyelitis - specifically biomedical research into ME – has been receiving increasingly more attention from both major research institutes in several countries as well as national health organisations. The Medical Research Council (MRC) in the UK, the Food & Drug Administration and Centres for Disease Control and Prevention in USA have created initiatives for new biomedical research into ME. In Norway the Norwegian Health Directorate have allocated funding for biomedical research into ME following the 2011 double blind randomised clinical trial using Rituximab (Anti-CD20 monoclonal antibody) by Fluge et al (PLoS 6:10.Oct 2011) to successfully treat ME patients.
There is increasing research evidence of immune dysfunction in ME patients.
The UK MRC states -
“There is now preliminary evidence supporting the view that inflammatory mechanisms in the brain and spinal cord may underlie the pathophysiology of some severe disease CFS/ME phenotypes. Biobanks are now becoming available and create a unique opportunity for interrogation.”
The IIMEC8 conference will show some of the major initiatives being taken to set up a collaborative strategy for biomedical research into ME to further this complex but exciting area of research leading to appropriate patient care and mainstreaming this field of research as well as this disease.
16th International Congress of Mucosal Immunology (ICMI 2013)
July 17-20, 2013 Vancouver, British Columbia, Canada
The 16th International Congress of Mucosal Immunology (ICMI 2013) is widely recognized as the pre-eminent conference on mucosal immunology, combining high-quality basic science with the clinical situation. ICMI 2013 is the only meeting where basic scientists, clinical researchers and industry professionals working at mucosal surfaces can meet to discuss the common and unique pathways of immunity and inflammation at different sites in the body.
Probiotics, Prebiotics, and the Host Microbiome: The Science of Translation
Wednesday, June 12, 2013 | 7:45 AM - 6:00 PM The New York Academy of Sciences
Presented by The Sackler Institute for Nutrition Science at the New York Academy of Sciences and The International Scientific Association for Probiotics and Prebiotics
In the past decade, researchers have observed a strong convergence of prebiotics, probiotics, and the microbiome in areas of host physiology such as the immune system, metabolism, and neurological function. This 1-day conference will serve as a neutral forum to critically examine the potential population-wide economic and public health benefits of translating this research into innovative functional foods and biotherapeutics for a broad spectrum of conditions including obesity, diabetes, inflammatory and gastrointestinal disease, and malnutrition. Participants will apply the rigorous standards of evidence-based medicine and evidence-based nutrition to evaluate and outline novel research and policy strategies to advance the incorporation of prebiotics- and probiotics-based applications to improve public health.
Thursday, June 27 through Sunday, June 30, 2013 Boston, Massachusetts
FOCIS is the meeting in translational immunology that will give you a competitive edge in your career. Stay ahead of the curve with leading clinicians and researchers delivering the latest breakthroughs across immune-mediated diseases. Focusing on molecular pathways and their implications in human disease provides the unique opportunity for innovative thinking and apply ideas from the pathologies of other diseases to uncover novel solutions to challenges in the diseases you study.
World-renowned speakers explore their work and touch on the FOCIS themes of: Immunoregulation, Immunodiagnosis, Immunogenetics, Immunotherapy and Host Defense. FOCIS has grown to 53 Member Societies that collectively represent over 65,000 basic and clinician scientists. The FOCIS meeting brings together these researchers and clinicians working in more than 30 clinical specialties and provides them with a forum to gather and share the latest findings, breakthroughs and therapies related to human disease. The FOCIS concept posits that interrelationships between fields sharing clinical immunology expertise will build a better and faster pathway to improve knowledge that leads to new therapies for inflammatory and immunologic diseases.